First Turn Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Other funds holding FULC
EC
TCM
NCM
SCM
First Turn Management's FULC Position: Q2 2026 in Review
First Turn Management sold out of Fulcrum Therapeutics (FULC) in Q2 2026, closing a stake of 2,256,109 shares — an estimated $17.3M sold.
First Turn Management first reported a position in FULC in Q4 2025 and held it in 2 quarters. The position peaked at $21.4M in Q4 2025. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.
- First Turn Management reported no remaining Fulcrum Therapeutics position as of Q2 2026 after selling out during the quarter.
- First Turn Management sold 2,256,109 Fulcrum Therapeutics shares in Q2 2026, an estimated $17.3M.
- First Turn Management first reported a position in Fulcrum Therapeutics in Q4 2025 and held it in 2 quarters.
- First Turn Management's Fulcrum Therapeutics position peaked at $21.4M in Q4 2025.
- 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.
Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.